Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-06-03 16:00 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,162 vol |
94,570 | |
Filed 2025-02-19 16:22 Tx date 2025-02-16 |
$SVA
Sernova Biotherapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+420,000 vol $0.25 each |
420,000 | |
Filed 2025-02-19 16:22 Tx date 2025-01-10 |
$SVA
Sernova Biotherapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-06-18 16:47 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,472 vol |
62,408 | |
Filed 2023-06-05 16:50 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,493 vol |
33,936 | |
Filed 2023-03-09 20:38 Tx date 2023-03-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,443 vol |
26,443 | |
Filed 2023-03-09 20:34 Tx date 2023-03-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-03-09 17:42 Tx date 2023-03-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
26,443 | ||
Filed 2023-03-09 17:42 Tx date 2023-03-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|